Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 13 Relevant journals,15 Conferences,12 Workshops are presently dedicated exclusively to breathing disorder and about 312 articles are being published on chronic obstructive Pulmonary Disease.
Chronic obstructive pulmonary disease (COPD), also known as chronic obstructive lung disease (COLD), and chronic obstructive airway disease (COAD), chronic obstructive pulmonary disease (COPD) is the name for a collection of lung diseases including chronic bronchitis, emphysema and chronic obstructive airways disease. Chronic bronchitis, which involves a long-term cough with mucus, Chronic bronchitis is an inflammation of the lining of your bronchial tubes, which carry air to and from your lungs Emphysema, which involves damage to the lungs over time. Emphysema occurs when the air sacs (alveoli) at the end of the smallest air passages (bronchioles) in the lungs are gradually destroyed. People with COPD have difficulties breathing, primarily due to the narrowing of their airways, this is called airflow obstruction. Damage to your lungs from COPD can't be reversed, but treatment can help control symptoms and minimize further damage.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Chronic Obstructive Pulmonary Disease: COPD is the fifth commonest cause of death in England and Wales, accounting for nearly 28,000 deaths each year and Britain has one of the highest death rates from COPD in the European Union. It is estimated that there are about 600,000 patients in the UK with diagnosed COPD and there may be as many again who remain undiagnosed. COPD patients are frequent users of primary and secondary care services with an estimate of one in eight hospital admissions being due to COPD. Consultation rates in general practice rise with age from 417 in those aged 45–64 per 10,000 populations per year to 1032 in those aged 75–84 per year per 10,000 populations (BTS, 1997). COPD results in an estimated 27 million lost working days per year.
Chronic bronchitis, which involves a long-term cough with mucus, Chronic bronchitis is an inflammation of the lining of your bronchial tubes, which carry air to and from your lungs • Emphysema, which involves damage to the lungs over time. Emphysema occurs when the air sacs (alveoli) at the end of the smallest air passages (bronchioles) in the lungs are gradually destroyed. People with COPD have difficulties breathing, primarily due to the narrowing of their airways, this is called airflow obstruction. Damage to your lungs from COPD can't be reversed, but treatment can help control symptoms and minimize further damage.
Typical symptoms of COPD include:
• increasing breathlessness when active
• a persistent cough with phlegm
• frequent chest infections
• Fatigue
• Many respiratory infections
• Trouble catching one's breath
• Wheezing
Causes and risk factors of COPD: cigarette smoking – the most significant risk factor. Around 20 to 25 per cent of smokers will develop COPD. Ex-smokers remain at risk and should be aware of symptoms of breathlessness long-term exposure to lung irritants – such as chemical vapors or dust from grain or wood. Severe air pollution can make COPD worse in smoker’s genes – a genetic disorder known as alpha-1-antitrypsin deficiency can trigger emphysema, even if no other risk factors are present. Diagnosis: It is important that COPD is diagnosed as early as possible so treatment can be used to try to slow down the deterioration of your lungs. You should see your GP if you have any of the symptoms mentioned above.
COPD is usually diagnosed after a consultation with your doctor, which may be followed by breathing tests. Treatment: There is no cure for COPD. But there are many things you can do to relieve symptoms and keep the disease from getting worse. If you smoke, now is the time to quit. This is the best way to slow lung damage.
Medicines used to treat COPD include:
• Inhalers (bronchodilators) to help open the airways
• Inhaled or oral steroids to reduce lung inflammation
• Anti-inflammatory drugs to reduce swelling in the airways
In severe cases or during flare-ups, you may need to receive: • Steroids by mouth or through a vein (intravenously)
• Bronchodilators through a nebulizer
• Oxygen therapy
• Assistance during breathing from a machine (through a mask, BiPAP, or endotracheal tube)
Your doctor may prescribe antibiotics during symptom flare-ups, because infections can make COPD worse. You may need oxygen therapy at home if you have a low level of oxygen in your blood.
Market Analysis:
The United Kingdom respiratory care market, Based on anatomical features, the respiratory system is segmented into upper respiratory tract and lower respiratory tract. The upper respiratory tract comprises pharynx, larynx, and nasal passages, while the lower respiratory tract includes trachea, lungs, and bronchi. Respiratory disease is a medical condition that affects the structure and organs associated with respiration or breathing. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia. Moreover, growing geriatric population and technological advancements would drive the global respiratory disease testing market. However, low adoption rate of digital radiography and portable spirometers are projected to hold back the growth of respiratory disease testing market from 2014 to 2022. The global respiratory disease testing market was valued at USD 2,326.5 million in 2013 and is estimated to reach USD 3,143.3 million in 2022, expanding at a CAGR of 3.4% from 2014 to 2022. For instance, the Centers for Disease Control and Prevention (CDC) published in 2012 that around 18.7 million adults in the U.K. were suffering from asthma. The American Lung Association states that COPD is the third leading cause of death in the U.K.
3rd Rhinology and Otology Conference <br>April 25-27, 2016 Dubai, UAE
4th Bacteriology and Infectious Diseases Conference <br>May 16-18, 2016 San Antonio, USA
2nd Respiratory and Pulmonary Medicine Conference <br>May 09-10, 2016 Chicago, USA
3rd COPD conference <br>July 11-12, 2016 Brisbane, Australia
2nd Infectious Diseases Conference: <br>August 25-27, 2016 Philadelphia, USA
Global Influenza Conferences <br>August 24-26, 2015 West Drayton, London, UK
4th Lung and Respiratory Care Conference <br>Aug-1-3, 2016 Manchester, UK
4th Immunology Conference <br>September 28-30, 2015 Houston, Texas, USA
Infectious Diseases and Diagnostic Microbiology Conference <br>Oct 3-5, 2016 Vancouver, Canada
2nd Flu Conference <br>November 17-19, 2016 San Francisco, USA
Indian Chest Society and Chest Physicians 17th Joint National Conference
November 4-7, 2015, Jaipur, India.
11th Respiratory Diseases conference
October 8-11, 2015, Chengdu, India
CHEST 2015 Conference:
October 24-28, Canada
46th Lung Health Conference, Cape Town, South Africa,
Dec: 2-6, 2015
20th Congress of the Asia Pacific Society of Respirology, Malaysia,
Dec-2-3, 2015
5th TB and Lung Disease Conference - Asia Pacific Region:
Aug-31, Sep- 2, 2015, Sydney
Respiratory Pathogens Conference:
Sep 2-4, 2015, Singapore
Respiratory Diseases Conference:
Sep3-6, Guiyang City
Respiratory Care Indonesia:
Sep2-4, Shangri-La Hotel
16th Lung Cancer Conference:
September 6 - 9 2015 Colorado, USA
European Respiratory Society International Congress:
26 September 2015, Amsterdam
Relevant Societies and Associations:
Cambridge Development Initiative
Cambridge Graduate Course in Medicine Society
Cambridge Romanian Society
Research Drones Society, Oxford
Midland Geotechnical Society – UK
Palaeontological Association – UK
The British Hospitality Association
National Housing Federation
Self-Storage Association UK
Vietnam Respiratory Society
Lung Health UK
British Lung Foundation
British Thoracic Society
British Association for Lung Research
The Sarcoidosis charity
The Freeman Heart & Lung Transplant Association
British Snoring and Sleep Apnoea Association
Association of Respiratory Nurses (ARNS)
Association of charted Physiotherapists in respiratory care (ACPRC)
List of Companies and retreat centers:
GlaxoSmithKline
Pfizer
Sanofi-Aventis
AstraZeneca
Novartis
Roche
Wyeth
Merk & Co
Lilly
Boehringer Ingelheim
Johnson & Johnson
Schering Plough
Novo Nordisk
Bayer Schering
Abbott
Teva
Bristol-Myers Squibb
Mundi Int
Gilead Sciences
Servier
Edwards Lifesciences
British American Tobacco
Imperial Tobacco Group
Reckitt Benckiser Group
Acm Global Central Laboratory Services Ltd
Acorn Polymers (U K ) Ltd
Access Health Products
Acm Global Central Laboratory Services Ltd
Acorn Equipment Co Ltd
Advanced Healthcare Ltd
This page will be updated regularly.
This page was last updated on November 22, 2024
